Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim

Clinical trial NCT01439321 · COMPLETED

Trial details

NCT number: NCT01439321
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Immune Thrombocytopenic Purpura

Start date: 2010-11-01
Primary completion: 2011-06-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.